“Vas+deferens”的搜索结果，显示 811-820 项，共有 7806 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this multicenter prospective observational case-control study is to train and validate Adela's cfMeDIP-seq based methylome profiling platform ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The Neuro-Oncology Program Registry and Biobank will be used for research purposes to increase our understanding of nervous system tumors. Benevolent Tumor ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   To determine the maximally tolerated dose (MTD) of intratumoral administration of an Edmonston strain measeles virus genetically engineered to express NAP ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   To determine the maximally tolerated dose (MTD) of intratumoral administration of an Edmonston strain measeles virus genetically engineered to express NAP ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...